γA/γ′ fibrinogen inhibits thrombin-induced platelet aggregation

Thrombosis and Haemostasis

Volumn 100, Issue 5, 2008, Pages 837-846

  Lovely, Rehana S ^a   Rein, Chantelle M ^b   White, Tara C ^b   Jouihan, Sari A ^b   Boshkov, Lynn K ^b   Bakke, Antony C ^b   McCarty, Owen J ^b   Farrell, David H ^b  

^a MISSOURI STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiplatelet agents; Antithrombin; Fibrinogen fibrin; Protease activated receptors (par); Thrombin

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; FIBRINOGEN; FIBRINOGEN GAMMA A CHAIN; FIBRINOGEN GAMMA CHAIN; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; UNCLASSIFIED DRUG; FIBRINOPEPTIDES GAMMA; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IC 50; IMMOBILIZATION; INHIBITION KINETICS; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; BLOOD CLOTTING PARAMETERS; METABOLISM; THROMBOCYTE; THROMBOCYTE ADHESIVENESS; TIME;

BLOOD PLATELETS; FIBRINOGEN; HUMANS; PEPTIDE FRAGMENTS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PROTEIN BINDING; RECEPTOR, PAR-1; THROMBIN; TIME FACTORS;

EID: 55549133300     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-03-0145     Document Type: Article

References (50)

1. Lord ST. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hematol 2007; 14: 236-241.
2. Henschen-Edman AH. Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease. Ann NY Acad Sci 2001; 936: 580-593.
3. Pan Y, Doolittle RF. cDNA sequence of a second fibrinogen α chain in lamprey: an archetypal version alignable with full-length β and γ chains. Proc Natl Acad Sci USA 1992; 89: 2066-2070.
4. Fu Y, Weissbach L, Plant PW, et al. Carboxy-terminal-extended variant of the human fibrinogen a subunit: a novel exon conferring marked homology to β and γ subunits. Biochemistry 1992; 31: 11968-11972.
5. Chung DW, Davie EW. γ and γ′ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236.
6. Fornace AJ, Cummings DE, Comeau CM, et al. Structure of the human γ-fibrinogen gene, alternate mRNA splicing near the 3′ end of the gene produces γA and γB forms of γ-fibrinogen. J Biol Chem 1984; 259: 12826-12830.
7. Wolfenstein-Todel C, Mosesson MW. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal γ chain variant (γ′). Proc Natl Acad Sci U S A 1980; 77: 5069-5073.
8. Legrele CD, Wolfenstein-Todel C, Hurbourg Y, et al. Evidence for two classes of rat plasma fibrinogen γ chains differing by their COOH-terminal amino acid sequences. Biochem Biophys Res Commun 1982; 105: 521-529.
9. Lovely RS, Falls LA, Al-Mondhiry HA, et al. Association of γA/γ′ fibrinogen levels and coronary artery disease. Thromb Haemost 2002; 88: 26-31.
10. Farrell DH, Thiagarajan P, Chung DW, et al. Role of fibrinogen α and γ chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-10732.
11. Kirschbaum NE, Mosesson MW, Amrani DL. Characterization of the γ chain platelet binding site on fibrinogen fragment D. Blood 1992; 79: 2643-2648.
12. Lawrence SO, Wright TW, Francis CW, et al. Purification and characterization of homodimeric γB-γB fibrinogen from rat plasma. Blood 1993; 82: 2406-2413.
13. Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994; 269: 226-231.
14. Siebenlist KR, Meh DA, Mosesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains. Biochemistry 1996; 35: 10448-10453.
15. Moaddel M, Farrell DH, Daugherty MA, et al. Interactions of human fibrinogens with factor XIII, roles of calcium and the γ′ peptide. Biochemistry 2000; 39: 6698-6705.
16. Meh DA, Siebenlist KR, Mosesson MW. Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem 1996; 271: 23121-23125.
17. Meh DA, Siebenlist KR, Brennan SO, et al. The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thromb Haemost 2001; 85: 470-474.
18. Lovely RS, Moaddel M, Farrell DH. Fibrinogen γ′ chain binds thrombin exosite II. J Thromb Haemost 2003; 1: 124-131.
19. Fredenburgh JC, Stafford AR, Leslie BA, et al. Bivalent binding to γA/γ′-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J Biol Chem 2008; 283: 2470-2477.
20. Sabo TM, Farrell DH, Maurer MC. Conformational analysis of g′ peptide (410-427) interactions with thrombin anion binding exosite II. Biochemistry 2006; 45: 7434-7445.
21. Pineda AO, Chen ZW, Marino F, et al. Crystal structure of thrombin in complex with fibrinogen γ′ peptide. Biophys Chem 2007; 125: 556-559.
22. Falls LA, Farrell DH. Resistance of γA/γ′ fibrin clots to fibrinolysis. J Biol Chem 1997; 272: 14251-14256.
23. Collet JP, Nagaswami C, Farrell DH, et al. Influence of γ′ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol 2004; 24: 382-286.
24. Siebenlist KR, Mosesson MW, Hernandez I, et al. Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains. Blood 2005; 106: 2730-2736.
25. Weiler H. Mouse models of thrombosis: thrombomodulin. Thromb Haemost 2004; 92: 467-477.
26. Celikel R, McClintock RA, Roberts JR, et al. Modulation of α-thrombin function by distinct interactions with platelet glycoprotein Ibα. Science 2003; 301: 218-221.
27. Dumas JJ, Kumar R, Seehra J, et al. Crystal structure of the GPIbα-thrombin complex essential for platelet aggregation. Science 2003; 301: 222-226.
28. De Candia E, Hall SW, Rutella S, et al. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001; 276: 4692-4698.
29. Li CQ, Vindigni A, Sadler JE, et al. Platelet glycoprotein Ibα binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin. J Biol Chem 2001; 276: 6161-6168.
30. Pechik I, Madrazo J, Mosesson MW, et al. Crystal structure of the complex between thrombin and the central 'E' region of fibrin. Proc Natl Acad Sci USA 2004; 101: 2718-27123.
31. Lovely RS, Boshkov LK, Marzec UM, et al. Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway. Br J Haematol 2007; 139: 494-503.
32. de Bosch NB, Mosesson MW, Ruiz-Saez A, et al. Inhibition of thrombin generation in plasma by fibrin formation (antithrombin I). Thromb Haemost 2002; 88: 253-258.
33. McCarty OJ, Calaminus SD, Berndt MC, et al. von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectively. J Thromb Haemost 2006; 4: 1367-1378.
34. White TC, Berny MA, Robinson DK, et al. The leech product saratin is a potent inhibitor of platelet integrin α2β1 and von Willebrand factor binding to collagen. FEBS J 2007; 274: 1481-1491.
35. Hawiger J. Adhesive ends of fibrinogen and its anti-adhesive peptides, the end of a saga? Semin Hematol 1995; 32: 99-109.
36. Peerschke EIB, Francis CW, Marder VJ. Fibrinogen binding to human blood platelets: effect of γ chain carboxyterminal structure and length. Blood 1986; 67: 385-390.
37. Amrani DL, Newman PJ, Meh D, et al. The role of fibrinogen Aα chains in ADP-induced platelet aggregation in the presence of fibrinogen molecules containing γ′ chains. Blood 1988; 72: 919-924.
38. 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin. Blood 1989; 74: 2437-2444.
39. Berny MA, White TC, Tucker EI, et al. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist. Arterioscler Thromb Vasc Biol 2008; 28: 329-334.
40. Brass LF, Pizarro S, Ahuja M, et al. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 1994; 269: 2943-2952.
41. Seegers WH, Nieft M, Loomis EC. Note on the adsorption of thrombin on fibrin. Science 1945; 101: 520-521.
42. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89: 9-12.
43. Francis CW, Nachman RL, Marder VJ. Plasma and platelet fibrinogen differ in γ chain content. Thromb Haemost 1984; 51: 84-88.
44. Mosesson MW, Homandberg GA, Amrani DL. Human platelet fibrinogen γ chain structure. Blood 1984; 63: 990-995.
45. Drouet L, Paolucci F, Pasqualini N, et al. Plasma γ′/γ fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor? Blood Coagul Fibrinolysis 1999; 10(Suppl) 1: S35-S39.
46. Mannila MN, Lovely RS, Kazmierczak SC, et al. Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost 2007; 5: 766-773.
47. Cheung EY, de Willige SU, Vos HL, et al. Fibrinogen γ′ in ischemic stroke: a case-control study. Stroke 2008; 39: 1033-1035.
48. Mosesson MW, Hernandez I, Raife TJ, et al. Plasma fibrinogen γ′ chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost 2007; 5: 62-69.
49. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, et al. Genetic variation in the fibrinogen g gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels. Blood 2005; 106: 4176-4183.
50. Mann KG, Brummel-Ziedins K, Orfeo T, et al. Models of blood coagulation. Blood Cells Mol Dis 2006; 36: 108-117.